How to achieve international action on falsified and substandard medicines.

How to achieve international action on falsified and substandard medicines.

מידע ביבליוגרפי
Main Authors:	Attaran, A, Barry, D, Basheer, S, Bate, R, Benton, D, Chauvin, J, Garrett, L, Kickbusch, I, Kohler, J, Midha, K, Newton, P, Nishtar, S, Orhii, P, McKee, M
פורמט:	Journal article
שפה:	English
יצא לאור:	2012

פריטים דומים

Combatting substandard and falsified medicines: a view from Rwanda.
מאת: Agnes Binagwaho, et al.
יצא לאור: (2013-01-01)

Trade in substandard and falsified medicines
מאת: Hagen, N, et al.
יצא לאור: (2022)

Substandard and Falsified Medicines in Myanmar
מאת: Mirai Sakuda, et al.
יצא לאור: (2020-03-01)

Substandard and falsified antibiotics: neglected drivers of antimicrobial resistance?
מאת: Zabala, GA, et al.
יצא לאור: (2022)

Substandard and falsified antibiotics: neglected drivers of antimicrobial resistance?
מאת: Paul N Newton, et al.
יצא לאור: (2022-08-01)

A random survey of the prevalence of falsified and substandard antibiotics in the Lao PDR
מאת: Tabernero, P, et al.
יצא לאור: (2022)

A random survey of the prevalence of falsified and substandard antibiotics in the Lao PDR
מאת: Tabernero, P, et al.
יצא לאור: (2019)

The uncertain role of substandard and falsified medicines in the emergence and spread of antimicrobial resistance
מאת: Cavany, S, et al.
יצא לאור: (2023)

The economic impact of substandard and falsified antimalarial medications in Nigeria.
מאת: Sarah M Beargie, et al.
יצא לאור: (2019-01-01)

The uncertain role of substandard and falsified medicines in the emergence and spread of antimicrobial resistance
מאת: Sean Cavany, et al.
יצא לאור: (2023-10-01)

The need for comprehensive and multidisciplinary training in substandard and falsified medicines for pharmacists
מאת: Veronika J Wirtz, et al.
יצא לאור: (2019-07-01)

Substandard, falsified and unregistered medicines in Latin America, 2017-2018
מאת: Robin Rojas-Cortés
יצא לאור: (2020-10-01)

The concept of substandard (falsified and poor quality) industrial products and its types
מאת: K. A. Utarov, et al.
יצא לאור: (2022-09-01)

The concept of substandard (falsified and poor quality) industrial products and its types
מאת: K. A. Utarov, et al.
יצא לאור: (2022-09-01)

Exploring pharmacists' perspectives about substandard and falsified medical products through interviews
מאת: A. Persson, et al.
יצא לאור: (2024-03-01)

Substandard and Falsified Medicines: Proposed Methods for Case Finding and Sentinel Surveillance
מאת: Elizabeth Pisani, et al.
יצא לאור: (2021-08-01)

Technologies for detecting falsified and substandard drugs in low and middle-income countries.
מאת: Stephanie Kovacs, et al.
יצא לאור: (2014-01-01)

Falsified and substandard medicines trafficking: A wakeup call for the African continent
מאת: Yusuf Hassan Wada, et al.
יצא לאור: (2022-06-01)

Combatting Substandard and Falsified Medicines: Public Awareness and Identification of Counterfeit Medications
מאת: Faris El-Dahiyat, et al.
יצא לאור: (2021-10-01)

Substandard and falsified medical products: bibliometric analysis and mapping of scientific research
מאת: Waleed M. Sweileh
יצא לאור: (2021-09-01)

Mobile apps for detecting falsified and substandard drugs: A systematic review.
מאת: Agustín Ciapponi, et al.
יצא לאור: (2021-01-01)

Substandard and falsified antimicrobials in selected east African countries: A systematic review.
מאת: Addisu Afrassa Tegegne, et al.
יצא לאור: (2024-01-01)

Substandard and falsified antimicrobials in selected east African countries: A systematic review
מאת: Addisu Afrassa Tegegne, et al.
יצא לאור: (2024-01-01)

Tackling the global impact of substandard and falsified and unregistered/unlicensed anti-tuberculosis medicines
מאת: Tamara Akpobolokemi, et al.
יצא לאור: (2022-01-01)

The Future of Falsified and Substandard Medicine Detection: Digital Methods To Track and Authenticate Pharmaceutical Products
מאת: Naughton, B
יצא לאור: (2018)

Identification of substandard and falsified medicines: influence of different tolerance limits and use of authenticity inquiries
מאת: Hauk, C, et al.
יצא לאור: (2021)

Comparing the return on investment of technologies to detect substandard and falsified amoxicillin: A Kenya case study.
מאת: Colleen R Higgins, et al.
יצא לאור: (2023-01-01)

Comparing the return on investment of technologies to detect substandard and falsified amoxicillin: A Kenya case study
מאת: Colleen R. Higgins, et al.
יצא לאור: (2023-01-01)

Substandard, Spurious, Falsely-Labelled, Falsified and Counterfeit (SSFFC) Drugs: Time to Take a Bitter Pill
מאת: Geetha Mani, et al.
יצא לאור: (2016-10-01)

Prevalence of substandard, falsified, unlicensed and unregistered medicine and its associated factors in Africa: a systematic review
מאת: Biset Asrade Mekonnen, et al.
יצא לאור: (2024-12-01)

Quantitative screening of the pharmaceutical ingredient for the rapid identification of substandard and falsified medicines using reflectance infrared spectroscopy.
מאת: Graham Lawson, et al.
יצא לאור: (2018-01-01)

A cross-sectional analysis of falsified, counterfeit and substandard medicines in a low-middle income country
מאת: Daariimaa Khurelbat, et al.
יצא לאור: (2020-05-01)

Surveillance for falsified and substandard medicines in Africa and Asia by local organizations using the low-cost GPHF Minilab.
מאת: Albert Petersen, et al.
יצא לאור: (2017-01-01)

Development of an agent-based model to assess the impact of substandard and falsified anti-malarials: Uganda case study
מאת: Sachiko Ozawa, et al.
יצא לאור: (2019-01-01)

Cost savings of paper analytical devices (PADs) to detect substandard and falsified antibiotics: Kenya case study
מאת: Hui-Han Chen, et al.
יצא לאור: (2021-03-01)

A systematic review of substandard, falsified, unlicensed and unregistered medicine sampling studies: a focus on context, prevalence, and quality
מאת: McManus, D, et al.
יצא לאור: (2020)

Prevention, Detection and Response to incidences of substandard and falsified medical products in the Member States of the Southern African Development Community
מאת: Stanislav Kniazkov, et al.
יצא לאור: (2020-12-01)

A systematic review of substandard, falsified, unlicensed and unregistered medicine sampling studies: a focus on context, prevalence, and quality
מאת: Dominic McManus, et al.
יצא לאור: (2020-08-01)

Uncovering the Quality Deficiencies with Potentially Harmful Effects in Substandard and Falsified PDE-5 Inhibitors Seized by Belgian Controlling Agencies
מאת: Celine Vanhee, et al.
יצא לאור: (2023-07-01)

Unveiling the Peril of Substandard and Falsified Medicines to Public Health and Safety in Africa: Need for All-Out War to End the Menace
מאת: Nafiu Aminu, et al.
יצא לאור: (2017-01-01)